Spravato Therapy Long Island: FDA-Approved Nasal Spray for Treatment-Resistant Depression

You’ve done everything right. Taken your medications as prescribed. Waited the weeks your doctor recommended. Tried a second antidepressant when the first one fell short, then maybe a third. And still, depression keeps its grip on your life. If this describes your experience, you’re facing what psychiatrists call treatment-resistant depression, and you’re far from alone. About one-third of people with depression don’t respond adequately to conventional medications.

Spravato therapy on Long Island offers a genuinely different approach. Unlike the pills you’ve already tried, Spravato (esketamine) works through an entirely new mechanism in your brain and comes as a simple nasal spray rather than another pill to swallow. The FDA approved it specifically for people like you who haven’t found relief from standard antidepressants. Even better, because it has FDA approval, most insurance plans cover Spravato for qualifying patients.

At Anxiety & Depression Psychiatry, our board-certified psychiatrists provide Spravato treatment at our Great Neck and Mineola offices. We’re not just a Spravato clinic. We’re a full-service psychiatric practice that treats the whole person, integrating this innovative treatment into comprehensive mental health care.

Spravato (esketamine) represents the most significant advancement in depression treatment in over three decades. The FDA approved it in March 2019 as the first and only nasal spray designed specifically for treatment-resistant depression in adults. In 2020, approval expanded to include adults with major depressive disorder who experience suicidal thoughts or behaviors.

Here’s what makes Spravato different from every antidepressant you’ve tried before. Traditional medications like SSRIs and SNRIs work by affecting serotonin, norepinephrine, or dopamine in your brain. When these don’t work well enough, it often means your depression involves different brain pathways entirely. Spravato targets the glutamate system and NMDA receptors, promoting neuroplasticity, which is your brain’s ability to form new neural connections and break free from stuck patterns.

Think of depression as grooves worn into a record, playing the same sad song on repeat. Spravato helps your brain create new pathways, essentially allowing it to play a different tune. This explains why Spravato therapy Long Island patients often notice improvement within hours or days rather than the weeks or months required by conventional antidepressants.

The treatment itself couldn’t be simpler. You’ll self-administer the nasal spray under our supervision, similar to using an over-the-counter allergy spray. No needles, no IV lines, no injections.

Spravato earned FDA approval through rigorous clinical trials involving thousands of patients with treatment-resistant depression. The evidence supporting its effectiveness is substantial.

The TRANSFORM-2 trial found that patients receiving Spravato alongside an oral antidepressant showed significantly greater improvement in depression symptoms compared to those receiving a placebo plus antidepressant. Patients in the Spravato group were 70% more likely to achieve remission, with many experiencing noticeable improvement within 24 hours of their first treatment.

The SUSTAIN-1 trial published in JAMA Psychiatry demonstrated that continuing Spravato treatment significantly reduced the risk of relapse. Patients who stopped Spravato were much more likely to see their depression return compared to those who continued maintenance treatment. This finding confirms that Spravato provides lasting benefits when used appropriately.

Key findings from the clinical research include:

• Spravato promotes rapid formation of new synaptic connections in brain regions that regulate mood
• Effects often begin within hours, not the weeks required by traditional antidepressants
• The treatment helps restore neural connections damaged by chronic stress and depression
• Long-term studies confirm sustained improvement with proper maintenance treatment

For Long Island residents who’ve struggled for years without adequate relief, these research findings represent genuine hope backed by solid science.

Spravato has FDA approval for specific conditions, ensuring you receive a treatment with proven safety and effectiveness. At Anxiety & Depression Psychiatry, we offer Spravato for:

If you’re dealing with anxiety, PTSD, OCD, or bipolar depression, our practice also offers IV ketamine therapy, which has broader applications beyond FDA-approved indications. During your consultation, we’ll help determine which treatment makes the most sense for your specific situation.

We’ve designed every step of your Spravato therapy Long Island experience to be comfortable, safe, and focused on your individual needs. Here’s what to expect.

You’ve already demonstrated incredible persistence by trying medication after medication. Now there’s an FDA-approved option that works through a completely different mechanism, comes as a simple nasal spray, and is covered by most insurance plans.

Spravato therapy on Long Island could be the breakthrough you’ve been searching for. At Anxiety & Depression Psychiatry, our board-certified psychiatrists will help you determine whether this treatment makes sense for your situation and guide you through every step of the process.

Call us at (646) 830-0131 to schedule a consultation. We’ll answer your questions honestly and help you understand your options. There’s no pressure, and everything you share remains completely confidential.

You don’t have to keep struggling with depression that won’t respond to traditional treatments. A different approach is available.

Monday – Friday 8am – 5pm

Board-certified psychiatrists • Insurance coverage available • Two Long Island locations